| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |